Thus, while high tumor chemerin concentrations have an anti-tumoral effect in other cancers [52,77,78,79], these effects may be masked in the context of esophageal cancers because of an immune tolerogenic phenotype. The gene discussed is RARRES2; the disease is neoplasm.